Eli Lilly announced plans for four new pharmaceutical manufacturing sites to produce domestic medicine production in the ...
A Johnson & Johnson unit working to resolve massive cancer litigation in bankruptcy court was accused by a former head of the ...
FDA reform needs to be underpinned by strategy, not ‘indiscriminate’ cuts The Trump administration could save the lives of ...
As we observe Rare Disease Day today, let us take a look at seven drugs poised to be approved to address rare diseases in ...
Rare Disease Day, an annual gathering hosted by the FDA and National Institutes of Health, was postponed. Medicare spending on 10 diabetes drugs, including popular GLP-1s, more than quadrupled over a ...
The company is leaning on its subcutaneous technology to deliver long-acting options that could prevent patients from cycling through drugs.
Novavax, Inc. faces declining revenues and high risks despite the Sanofi deal and cost-cutting measures. Click here for my ...
As Robert F. Kennedy Jr. takes the helm of the Department of Health and Human Services, his policies on chronic disease, ...
Zevra has sold its US Food and Drug Administration (FDA) priority review voucher (PRV) for $150m to an undisclosed party. The ...
As we have discussed previously, there is an outbreak of measles affecting unvaccinated children in the US. In an attempt to reassure the US public, Robert F. Kennedy Jr., said that the U.S.
Eisai plans to lay off 121 employees in the U.S. A former deputy director of China's drug agency is under investigation by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results